These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38342415)

  • 1. Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery.
    Baydemir I; Dulfer EA; Netea MG; Domínguez-Andrés J
    Clin Immunol; 2024 Apr; 261():109930. PubMed ID: 38342415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trained immunity-related vaccines: innate immune memory and heterologous protection against infections.
    Ziogas A; Netea MG
    Trends Mol Med; 2022 Jun; 28(6):497-512. PubMed ID: 35466062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations.
    Uthayakumar D; Paris S; Chapat L; Freyburger L; Poulet H; De Luca K
    Front Immunol; 2018; 9():2869. PubMed ID: 30564249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Trained Immunity by Recombinant Vaccines.
    Covián C; Ríos M; Berríos-Rojas RV; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():611946. PubMed ID: 33584692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring.
    Peng X; Zhou Y; Zhang B; Liang X; Feng J; Huang Y; Weng S; Xu Y; Su H
    J Biol Chem; 2024 Jan; 300(1):105518. PubMed ID: 38042489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
    Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
    Front Immunol; 2018; 9():2936. PubMed ID: 30619296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The causes and consequences of trained immunity in myeloid cells.
    Bhargavi G; Subbian S
    Front Immunol; 2024; 15():1365127. PubMed ID: 38665915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.
    Palgen JL; Feraoun Y; Dzangué-Tchoupou G; Joly C; Martinon F; Le Grand R; Beignon AS
    Front Immunol; 2021; 12():612747. PubMed ID: 33763063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
    Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
    Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
    Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
    Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current progress on trained immunity-based vaccines].
    Xiang CY; Wang N; Shi Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Oct; 58(10):1598-1603. PubMed ID: 39428246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of vaccine non-specific effects on licensure of new vaccines.
    Munkwase G
    Vaccine; 2024 Feb; 42(5):1013-1021. PubMed ID: 38242737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
    Parmar K; Siddiqui A; Nugent K
    Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trained immunity: consequences for the heterologous effects of BCG vaccination.
    Kleinnijenhuis J; van Crevel R; Netea MG
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):29-35. PubMed ID: 25573107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG-induced trained immunity: history, mechanisms and potential applications.
    Chen J; Gao L; Wu X; Fan Y; Liu M; Peng L; Song J; Li B; Liu A; Bao F
    J Transl Med; 2023 Feb; 21(1):106. PubMed ID: 36765373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific effects of vaccines: Current evidence and potential implications.
    de Bree LCJ; Koeken VACM; Joosten LAB; Aaby P; Benn CS; van Crevel R; Netea MG
    Semin Immunol; 2018 Oct; 39():35-43. PubMed ID: 30007489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.